There is more evidence of IRE1α suppressing different pro-inflammatory anti-tumor interferon signaling [143] and promoting the production of prostaglandin E2 (PGE2) [144], a known promoter of Treg differentiation [145], in prostate cancer and NSCLC, respectively. This evidence concerns the gene ERN1 and prostate cancer.